US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist

1.2199
+0.0199+1.66%

Close Aug 23 16:00 ET

1.2000
-0.0199-1.63%

Post 17:06 ET

2.41MMarket Cap-79P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-98.93%4K

29K

420K

31K

16K

373K

Operating revenue

-98.93%4K

--29K

--420K

--31K

--16K

--373K

--0

Cost of revenue

Gross profit

Operating expense

-42.11%3.65M

-40.10%4.38M

-6.45%25.87M

-39.05%5.39M

6.09%6.86M

8.94%6.3M

11.59%7.32M

23.52%27.66M

47.79%8.85M

7.82%6.47M

Selling and administrative expenses

3.17%1.63M

-3.83%1.58M

-8.99%6.72M

-12.60%1.87M

-20.89%1.63M

-0.32%1.58M

2.49%1.65M

-1.06%7.38M

10.41%2.14M

15.33%2.05M

-General and administrative expense

3.17%1.63M

-3.83%1.58M

-8.99%6.72M

-12.60%1.87M

-20.89%1.63M

-0.32%1.58M

2.49%1.65M

-1.06%7.38M

10.41%2.14M

15.33%2.05M

Research and development costs

-57.20%2.02M

-50.62%2.8M

-5.52%19.16M

-47.51%3.52M

18.65%5.24M

12.41%4.73M

14.53%5.67M

35.81%20.27M

65.73%6.7M

4.65%4.41M

Operating profit

38.54%-3.64M

40.50%-4.36M

7.97%-25.45M

39.40%-5.36M

-5.85%-6.85M

-2.49%-5.93M

-11.59%-7.32M

-23.52%-27.66M

-47.79%-8.85M

-7.82%-6.47M

Net non-operating interest income expense

-136.36%-28K

-98.28%2K

26.67%266K

-81.15%23K

-25.37%50K

352.94%77K

2,800.00%116K

1,212.50%210K

2,950.00%122K

1,575.00%67K

Non-operating interest income

----

-98.28%2K

26.67%266K

-81.15%23K

-25.37%50K

352.94%77K

2,800.00%116K

1,212.50%210K

2,950.00%122K

1,575.00%67K

Non-operating interest expense

--28K

----

Other net income (expense)

101.65%3K

-32.91%53K

-123.78%-364K

-28.52%-356K

-67.24%95K

-187.08%-182K

-93.96%79K

714.36%1.53M

-810.26%-277K

3,122.22%290K

Gain on sale of security

103.95%3K

101.15%1K

-277.68%-414K

-26.69%-356K

-62.32%104K

-136.36%-76K

-400.00%-87K

429.55%233K

-820.51%-281K

2,966.67%276K

Other non- operating income (expenses)

----

-68.67%52K

-96.15%50K

--0

-164.29%-9K

---106K

-87.03%166K

801.39%1.3M

--4K

--14K

Income before tax

39.19%-3.67M

39.64%-4.3M

1.40%-25.55M

36.74%-5.69M

-9.66%-6.7M

-8.54%-6.03M

-35.80%-7.12M

-16.81%-25.92M

-51.46%-9M

-2.09%-6.11M

Income tax

29.69%-412K

-2.58%-1.35M

36.49%-3M

73.31%-422K

34.12%-668K

40.45%-586K

-15.99%-1.32M

-26.53%-4.72M

-46.66%-1.58M

-1.60%-1.01M

Net income

40.22%-3.26M

49.24%-2.95M

-6.40%-22.56M

28.95%-5.27M

-18.37%-6.03M

-19.08%-5.45M

-41.29%-5.8M

-14.85%-21.2M

-52.53%-7.42M

-2.19%-5.1M

Net income continuous Operations

40.22%-3.26M

49.24%-2.95M

-6.40%-22.56M

28.95%-5.27M

-18.37%-6.03M

-19.08%-5.45M

-41.29%-5.8M

-14.85%-21.2M

-52.53%-7.42M

-2.19%-5.1M

Minority interest income

Net income attributable to the parent company

40.22%-3.26M

49.24%-2.95M

-6.40%-22.56M

28.95%-5.27M

-18.37%-6.03M

-19.08%-5.45M

-41.29%-5.8M

-14.85%-21.2M

-52.53%-7.42M

-2.19%-5.1M

Preferred stock dividends

0.00%201K

0.00%50K

0.00%201K

0.00%50K

Other preferred stock dividends

Net income attributable to common stockholders

40.76%-3.26M

49.68%-2.95M

-6.34%-22.76M

28.76%-5.32M

-18.19%-6.08M

-18.88%-5.5M

-40.79%-5.85M

-14.69%-21.4M

-51.99%-7.47M

-2.16%-5.15M

Basic earnings per share

89.04%-0.72

67.57%-2.27

6.79%-26.75

30.78%-6.23

-11.63%-7.2

4.78%-6.57

-11.11%-7

8.45%-28.7

-11.11%-9

20.37%-6.45

Diluted earnings per share

89.04%-0.72

67.57%-2.27

6.79%-26.75

30.78%-6.23

-11.63%-7.2

4.78%-6.57

-11.11%-7

8.45%-28.7

-11.11%-9

20.37%-6.45

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	-98.93%4K	29K	420K	31K	16K	373K	0	0	0	0
Operating revenue	-98.93%4K	--29K	--420K	--31K	--16K	--373K	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-42.11%3.65M	-40.10%4.38M	-6.45%25.87M	-39.05%5.39M	6.09%6.86M	8.94%6.3M	11.59%7.32M	23.52%27.66M	47.79%8.85M	7.82%6.47M
Selling and administrative expenses	3.17%1.63M	-3.83%1.58M	-8.99%6.72M	-12.60%1.87M	-20.89%1.63M	-0.32%1.58M	2.49%1.65M	-1.06%7.38M	10.41%2.14M	15.33%2.05M
-General and administrative expense	3.17%1.63M	-3.83%1.58M	-8.99%6.72M	-12.60%1.87M	-20.89%1.63M	-0.32%1.58M	2.49%1.65M	-1.06%7.38M	10.41%2.14M	15.33%2.05M
Research and development costs	-57.20%2.02M	-50.62%2.8M	-5.52%19.16M	-47.51%3.52M	18.65%5.24M	12.41%4.73M	14.53%5.67M	35.81%20.27M	65.73%6.7M	4.65%4.41M
Operating profit	38.54%-3.64M	40.50%-4.36M	7.97%-25.45M	39.40%-5.36M	-5.85%-6.85M	-2.49%-5.93M	-11.59%-7.32M	-23.52%-27.66M	-47.79%-8.85M	-7.82%-6.47M
Net non-operating interest income expense	-136.36%-28K	-98.28%2K	26.67%266K	-81.15%23K	-25.37%50K	352.94%77K	2,800.00%116K	1,212.50%210K	2,950.00%122K	1,575.00%67K
Non-operating interest income	----	-98.28%2K	26.67%266K	-81.15%23K	-25.37%50K	352.94%77K	2,800.00%116K	1,212.50%210K	2,950.00%122K	1,575.00%67K
Non-operating interest expense	--28K	----	----	----	----	----	----	----	----	----
Other net income (expense)	101.65%3K	-32.91%53K	-123.78%-364K	-28.52%-356K	-67.24%95K	-187.08%-182K	-93.96%79K	714.36%1.53M	-810.26%-277K	3,122.22%290K
Gain on sale of security	103.95%3K	101.15%1K	-277.68%-414K	-26.69%-356K	-62.32%104K	-136.36%-76K	-400.00%-87K	429.55%233K	-820.51%-281K	2,966.67%276K
Other non- operating income (expenses)	----	-68.67%52K	-96.15%50K	--0	-164.29%-9K	---106K	-87.03%166K	801.39%1.3M	--4K	--14K
Income before tax	39.19%-3.67M	39.64%-4.3M	1.40%-25.55M	36.74%-5.69M	-9.66%-6.7M	-8.54%-6.03M	-35.80%-7.12M	-16.81%-25.92M	-51.46%-9M	-2.09%-6.11M
Income tax	29.69%-412K	-2.58%-1.35M	36.49%-3M	73.31%-422K	34.12%-668K	40.45%-586K	-15.99%-1.32M	-26.53%-4.72M	-46.66%-1.58M	-1.60%-1.01M
Net income	40.22%-3.26M	49.24%-2.95M	-6.40%-22.56M	28.95%-5.27M	-18.37%-6.03M	-19.08%-5.45M	-41.29%-5.8M	-14.85%-21.2M	-52.53%-7.42M	-2.19%-5.1M
Net income continuous Operations	40.22%-3.26M	49.24%-2.95M	-6.40%-22.56M	28.95%-5.27M	-18.37%-6.03M	-19.08%-5.45M	-41.29%-5.8M	-14.85%-21.2M	-52.53%-7.42M	-2.19%-5.1M
Minority interest income
Net income attributable to the parent company	40.22%-3.26M	49.24%-2.95M	-6.40%-22.56M	28.95%-5.27M	-18.37%-6.03M	-19.08%-5.45M	-41.29%-5.8M	-14.85%-21.2M	-52.53%-7.42M	-2.19%-5.1M
Preferred stock dividends			0.00%201K	0.00%50K	0.00%50K	0.00%50K	0.00%50K	0.00%201K	0.00%50K	0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders	40.76%-3.26M	49.68%-2.95M	-6.34%-22.76M	28.76%-5.32M	-18.19%-6.08M	-18.88%-5.5M	-40.79%-5.85M	-14.69%-21.4M	-51.99%-7.47M	-2.16%-5.15M
Basic earnings per share	89.04%-0.72	67.57%-2.27	6.79%-26.75	30.78%-6.23	-11.63%-7.2	4.78%-6.57	-11.11%-7	8.45%-28.7	-11.11%-9	20.37%-6.45
Diluted earnings per share	89.04%-0.72	67.57%-2.27	6.79%-26.75	30.78%-6.23	-11.63%-7.2	4.78%-6.57	-11.11%-7	8.45%-28.7	-11.11%-9	20.37%-6.45
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall